eTectRx

Deals

(Photo by Klaus Vedfelt/Getty Images)

By  Laura Lovett 11:56 am April 6, 2021
Digital therapeutics company Pear Therapeutics is looking to integrate digital biomarkers, machine learning algorithms and sensor-based technologies into its platform thanks to new licensing deals and partnerships. The Boston-based DTx company has inked collaboration deals with Empatica and etectRx, as well as licensing tech from KeyWise. Specifically, Pear's collaboration with Empatica will...
etectRx
By  Laura Lovett 03:03 pm January 15, 2021
Earlier this week DTx company Pear Therapeutics inked a deal with adherence tool etectRx to potentially develop a product that combines the former’s digital therapeutics with a digital pill offering. As part of the deal the two companies will meet quarterly to discuss potential collaborations with the pharma industry. “Here we are talking about how can we bring this to pharma... we are going to...
By  Laura Lovett 02:18 pm August 24, 2020
Valerie Sullivan was named the next president of digital health company etectRx. This isn’t Sullivan’s first time working with the company. She has worked with the company in a consulting role for the last year. Her previous work experience includes serving as the president of InVentiv Patient Access Solutions and as the VP and general manager of the patient service center at Pear Therapeutics...
By  Dave Muoio 04:03 pm December 9, 2019
Gainesville, Florida-based etectRx has received FDA 510(k) clearance for its ID-Cap System, a prescription ingestible system that sends adherence event logs to an external medical device. Similar to the system pioneered by etectRx’s high-profile competitor, Proteus Digital Health, the ID-Cap’s core is a standard capsule containing a sensor that transmits a message once it comes into contact with...
By  Laura Lovett 02:04 pm March 4, 2019
A new study conducted at Brigham and Women’s Hospital in Boston in partnership with The Fenway Institute at Fenway Health will be using eTectRx’s ingestion event monitoring system to research adherence of the HIV prevention drug Truvada for pre-exposure prophylaxis (PrEP).  PrEP is a preventative drug designed to be taken by people who do not have HIV but are at risk for the condition. and must...
By  Dave Muoio 05:29 pm November 21, 2017
Opioid adherence remains a hot topic in healthcare amidst the US ongoing epidemic, and a solution may lie within the pills themselves. In a study recently published in Anesthesia & Analgesia, researchers testing eTectRx’s digital pill technology could allow practitioners to better understand patient opioid adherence, thereby paving the way to more appropriate dosage and use of the drugs. “We’...